Gynaecology
DISARM’s Citizen Awareness Campaign aims to improve public understanding of ovarian cancer symptoms, hereditary risk factors, and the importance of seeking timely medical advice through accessible and evidence-based information.
Ovarian cancer is often diagnosed too late, limiting treatment options and outcomes. Discover how DISARM is working to improve personalised risk assessment and develop new approaches for earlier detection.
In June 2026, DISARM held an online co-creation workshop with patients, clinicians, and researchers to help shape OVA-ONLINE, its new platform for ovarian cancer risk awareness and early detection.
From data governance and bias prevention to human oversight and accountability, learn how DISARM is embedding legal readiness into the development of AI tools for ovarian cancer risk assessment and early detection.
In this guest blog, our partners at the World Ovarian Cancer Coalition highlight the importance of visibility, storytelling, and collective action through the #ReachForTheScars campaign for World Ovarian Cancer Day 2026.
Welcome to the first edition of the brand new DISARM Newsletter!
As the European Society of Gynaecological Oncology calls for systemic reform in women’s cancer care, DISARM shows how EU-funded research is already turning that ambition into action.